Results 131 to 140 of about 23,728 (213)

Risk Factor Analysis Based on Disease Severity: Rosacea Disease Management Strategies and Personalized Recommendations. [PDF]

J Cosmet Dermatol
Liu H, Zhang L, Yuan J, Liang J, Zhang Y, Gao Z, Chen Y, Wang Y, Li Y, Zeng W, Yang F.   +10 more
europepmc   +1 more source

Increased Expression of Angiopoietin 2 and Tie2 in Rosacea. [PDF]

Dermatopathology (Basel)
Kaya A, Saurat JH, Satta N, Kaya G.
europepmc   +1 more source

Clinical Manifestations and Treatment Outcomes of Pediatric Rosacea Patients: A Retrospective Study. [PDF]

J Clin Med
Kim YJ, Park JM, Lee HM, Kim DH, Seo SH, Ahn HH.   +5 more
europepmc   +1 more source

Exploring New Dimensions in Longitudinal Rosacea Management. [PDF]

Dermatol Ther (Heidelb)
Schaller M, Welsh B, Micali G, Tan J, Del Rosso J, Harper J, Dirschka T, Cho S, Almeida LMC, Kon K, Barańska-Rybak W, Dayrit J, Stein Gold L.   +12 more
europepmc   +1 more source

Exploring the role of immune cell and inflammatory cytokines in the development of rosacea. [PDF]

Medicine (Baltimore)
Xu Y, Zhao J.
europepmc   +1 more source

Combination Therapy with Oral Doxycycline and Intradermal Botulinum Toxin Type A for Moderate-to-Severe Rosacea: A Randomized Controlled Trial.

Indian J Dermatol
Nguyen TT, Le DH, Vu HT, Vu LH, Vu MN, Pham PTM.   +5 more
europepmc   +1 more source

Topical medications for moderate-to-severe rosacea: protocol for a living systematic review and network meta-analysis. [PDF]

BMJ Open
Amstutz AV, Fladger A, Sanchez-Feliciano A, Barbieri JS.   +3 more
europepmc   +1 more source

Current Trends and Future Insights on Rosacea Treatment: A Bibliometric Analysis. [PDF]

Clin Cosmet Investig Dermatol
Wang D, Zhang J, Wang B, Gao J, Zhang G.
europepmc   +1 more source